International Journal of Medicine and Data

Objective To investigate the clinical value of plasma B-type natriuretic peptide in the detection and treatment of emergency patients with dyspnea; Methods 200 patients with clinical dyspnea were selected for the study (July 2019 to August 2022). They were divided into the observation group (n=100) and the control group (n=100) by the single and double sign method. The patients in the treatment group were diagnosed by routine detection after admission, and the plasma b-type natriuretic peptide was also detected. The effective rate and pulmonary artery pressure of the two kinds of patients were compared. Results According to the examination results, the detection rate in the observation group was 89%, while that in the control group was 79%. Compared with the two groups, the detection rate in the observation group was significantly higher, with a significant difference (P<0.05). It was found that the overall detection effective rate of the patients in the observation center was 99%, and the overall detection effective rate of the patients in the control group was 91%. Compared with the observation group, the overall detection effective rate of the two groups was significantly higher, with a significant difference (P<0.05). Compared with the control group, the pulmonary artery pressure level of the observed group was significantly higher (P<0.05). Conclusion The application of plasma B-type natriuretic peptide detection method in the detection of patients with emergency dyspnea shows the characteristics of high diagnostic effectiveness, which can provide sufficient basis for the later clinical diagnosis and treatment.

plasma b-type natriuresis; Emergency dyspnea; testing; diagnosis